PNAS PLUS Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed Juna

First Page		Document Content
Date: 2015-05-22 15:03:31 Blindness Anatomy Vascular endothelial growth factor PEDF Diabetic retinopathy Ranibizumab Hypoxia-inducible factors Angiogenesis Bevacizumab Angiology Medicine Biology		PNAS PLUS Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed Juna Add to Reading List Source URL: www.pnas.org Download Document from Source Website File Size: 1,25 MB Share Document on Facebook

	I am Joseph B . Wolffe, a doctor of medicine, a member of the American Medical Association and a founder member of the United States Committee of the World Medical Association . I am Medical Director of the Valley Forge DocID: 1robC - View Document
	■ VeriTran, Inc. is commercializing a patented Infinitely Variable Transmission (IVT) which allows variable pumping rates for optimizing production in oil field pump jacks. Installations to date validate production in DocID: 1qYRk - View Document
	Numeric Key of Factor levels for extraction parameters Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development – A Systematic Review Marianne Isabelle Martic-Kehl, DocID: 1qWRv - View Document
	SPECIAL SESSIONSpecial Session 31: Mathematical Models of Cancer and Cancer Therapy Yangjin Kim, KonKuk University, Korea DocID: 1qWxt - View Document
	Medical Questionnaire Date _______________________ Social Security ________________Date of Birth _______________ Name ____________________________________________________________________________ Address _________________ DocID: 1qRPW - View Document